EN DE
STOCK COMPARISON

IQVIA Holdings vs Thermo Fisher Scientific: Fair Value & Quality

Both stocks run through our valuation models. Here is how IQVIA Holdings (IQV) and Thermo Fisher Scientific (TMO) compare, as of Aug 8, 2026.

As of Aug 8, 2026, Fair Value Calculator sees IQVIA Holdings as the less overvalued of the two: IQVIA Holdings trades at $232 versus a fair value of $134 (-42%), while Thermo Fisher Scientific trades at $580 versus $308 (-47%).
IQVIA Holdings
IQV · USD · Health Care
-42%
upside to fair value
overvalued
Price$232
Fair Value$134
Quality58/100
Thermo Fisher Scientific
TMO · USD · Health Care
-47%
upside to fair value
overvalued
Price$580
Fair Value$308
Quality64/100

Head-to-head numbers

Green value = the better side for that row (for valuation multiples: lower = cheaper).

IQVIA HoldingsThermo Fisher Scientific
Valuation
25.9×P/E (TTM)29.5×
2.09×P/S (TTM)4.41×
5.33×P/B3.74×
15.5×EV/EBITDA20.0×
0.84×PEG1.74×
Dividend yield0.3%
Dividend per share$1.76
Profitability
8%Net margin15%
14%Operating margin18%
22%Return on equity14%
5%Return on assets5%
Growth
8%Revenue growth (YoY)6%
4.2%Avg. growth/yr (3Y)-0.3%
7.5%Avg. growth/yr (5Y)6.7%
Balance & size
2.14×Debt / equity0.67×
$35BMarket cap$199B
healthyGrowth qualityhealthy

IQVIA Holdings leads: 9 to 4 metric wins.

Dash = not meaningfully computable, for example with negative equity.

Quality in detail

The quality score, broken down into the same factor families as on the stock page, 0 to 100 per family.

IQVIA Holdingsof which business quality 55 · market factors 60 Thermo Fisher Scientificof which business quality 60 · market factors 63
ProfitabilityMargins and returns on capital today
43
43
Quality GrowthAre margins and returns improving?
31
31
CashflowEarnings quality: real cash, not paper profit
72
62
Fin. StrengthBalance sheet, leverage, solvency risk
22
60
InvestmentDisciplined investing over empire-building
81
79
Low VolatilityCalm price path (market factor)
44
68
MomentumPrice trend over the last 3–12 months (market factor)
63
56
52W MomentumDistance to the 52-week high (market factor)
74
68
Net IssuanceBuybacks instead of dilution
100
97

What the models say

The median fair value (base case) per model family, each in the currency of its trading venue. Green = above the current price, red = below.

IQVIA Holdings

DCF Models$142
Earnings-Based$65.68
Dividend Discount$6.22
Multiples$151
Asset-Based$26.11
Growth DCF$150
Economic Profit$80.72
Growth Earnings$123

26 of 26 models see the stock below the current price.

Thermo Fisher Scientific

DCF Models$331
Earnings-Based$203
Multiples$310
Asset-Based$96.29
Growth DCF$288
Economic Profit$159
Growth Earnings$324

24 of 24 models see the stock below the current price.

Scenario ranges

From our cautious bear case to the optimistic bull case. The white tick is the current price: left of fair value means room to run.

IQVIA Holdings
Bear $67.75Fair Value $134Bull $206
$232 = current price (white tick)
Thermo Fisher Scientific
Bear $175Fair Value $308Bull $385
$580 = current price (white tick)

Compare two other stocks

Tap a field and type again, ticker or company name.

Free, no sign-up

Ranked within their sector

Where each stock sits within its sector peer group. Band = middle 50% of peers, tick = median, dot = this stock.

IQVIA Holdings · Health Care

Quality score58 · above median
Fair value upside-42% · below median

Thermo Fisher Scientific · Health Care

Quality score64 · Top 25%
Fair value upside-47% · below median

Bottom line

As of Aug 8, 2026, Fair Value Calculator sees IQVIA Holdings as the less overvalued of the two: IQVIA Holdings trades at $232 versus a fair value of $134 (-42%), while Thermo Fisher Scientific trades at $580 versus $308 (-47%).

Thermo Fisher Scientific has the higher quality score (64/100).

See the full analysis →

More comparisons

Popular match-ups from the same sectors, all with fair value and quality score.

Free · Top-25 report

See the undervalued quality stocks every month

Just your email for the monthly Top-25 report of the most undervalued quality stocks, with fair value, quality and price target. Plus 14 days of Pro to try, no card.

Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click. Not financial advice.

A model-based valuation snapshot from 21 models. Values change with price and fundamentals; the date shown above applies.